SOAS incidents Mean/SD | Non-SOAS incidents Mean/SD | Statistical significance | |
---|---|---|---|
Total PANSSα | 85.5(25.3) | 72.4(21.4) | NS |
GAF-Sβ | 24.5(12.6) | 32.6(12.9) | NS |
GAF-Fβ | 23.4(9.3) | 33.8(12.4) | NS |
BVCγ | 2.54(1.9) | .60(.87) | P = .002 |
Side effects | NS | ||
Extrapyramidal | .00 (.00) | .02(.19) | |
Acathisia | .00(.00) | .05(.29) | |
Frequency of testing out and pushing limits | 1.46(1.12) | .50(.92) | NS |
Need to set limits | 1.54(1.05) | .53(1.97) | NS |
Intensity of testing out and pushing limits | 1.92((1.55) | .50(.98) | NS |
Segregation | 1.77(.43) | 1.50(.50) | P = .041 |
Diagnosis of schizophrenia | .46(.51) | .37(.48) | NS |
Diagnosis of substance abuse | .07(.27) | .21(.41) | NS |
Physician's prediction | 3.85(.55) | 2.70(.29) | P = .039 |
Medication | NS | ||
Hypnotics and sedatives | .31(.48) | .37(.48) | |
Anti-depressive | .08(.27) | .18(.38) | |
Anti-epileptic | .00(.00) | .16(.37) | |
Neuroleptic | .38(.50) | .31(.46) |